Vaccine candidates from Pfizer-BioNTech and Moderna received EUAs, as did the first at-home test that delivers results in 30 minutes, and two treatments for the virus.
Vaccine candidates from Pfizer-BioNTech and Moderna received EUAs, as did the first at-home test that delivers results in 30 minutes, and two treatments for the virus.
Veklury is approved for hospitalized patients, while bamlanivimab is being investigated in mild-to-moderate cases of COVID-19.
Even at recommended doses, benzodiazepine use can lead to misuse, abuse, and addiction.
Olinvyk injections and Qdolo oral solution are approved for the management of acute pain.
The FDA recommends healthcare professionals co-prescribe the opioid overdose reversal drug with all opioid prescriptions.
Subcutaneous injections of the new biologic, adalimumab-fkjp, were approved for seven indications.
The malaria drug loses an EUA for COVID-19, while the FDA warns of drug interactions that can reduce antiviral effectiveness.
Elyxyb (celecoxib) is an NSAID for the acute treatment of migraine with or without aura.
The FDA allows emergency use in response to positive trials, but more research is needed.
New developments with diagnostic testing and the use of chloroquine and hydroxychloroquine.
